Eli Lilly decision on €200m plan ‘under review’

Fears that pharmaceutical giant Eli Lilly’s decision to postpone a €200m investment in Kinsale, Co Cork are a reaction to US President Donald Trump’s protectionism are overstated, according to a leading economist.

An Eli Lilly spokesperson confirmed to the Irish Examiner that a final decision on whether to proceed with the proposed €200m investment in upgrading its Kinsale facility was now under review, as reported by The Sunday Business Post.

An eventual decision will be made by Lilly’s global board at the “appropriate stage of the process”, the spokesperson said.